Artelo Biosciences, Inc. (ARTL)
Nasdaq: ARTL · Pharmaceutical Preparations · Solana Beach, CA · filing with the SEC since 2014
Who runs Artelo Biosciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Secr. First filing Jun 2019, latest Feb 2, 2026, 9 filings in all.
Officers reporting now
2
of 8 people with a filing in the last fifteen months
Directors reporting now
6
10 people on the record since 2019
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Jun 2019 | Feb 2, 2026 | none |
| Spring Mark Edward | Chief Financial Officer | Nov 2025 | Feb 2, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Blayney Douglas | director | Jun 2019 | Jul 21, 2026 | none |
| Emanuele Robert Martin | director | Jun 2019 | Jul 21, 2026 | none |
| Favorito Tamara A | director | Mar 2021 | Jul 21, 2026 | none |
| Kelly Steven | director | Jun 2019 | Jul 21, 2026 | none |
| Matsui Connie | director | Jun 2019 | Jul 21, 2026 | none |
| Reyes Gregory | director | Dec 2020 | Jul 21, 2026 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.